The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate

Journal of Virology

Volumn 74, Issue 15, 2000, Pages 7039-7047

  Mansky, Louis M ^a,c   Preveral, Sandra ^b   Selig, Luc ^b,d   Benarous, Richard ^b   Benichou, Serge ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b INSERM   (France)

^c 2078 Graves Hall ^*  (United States)

^d Hybrigenics SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URACIL DNA GLYCOSYLTRANSFERASE; VIRUS VECTOR;

ARTICLE; BASE PAIRING; DNA REPAIR; ENZYME MODIFICATION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION RATE; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL NUCLEUS; COS CELLS; DNA GLYCOSYLASES; GENE PRODUCTS, VPR; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HELA CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; N-GLYCOSYL HYDROLASES; TWO-HYBRID SYSTEM TECHNIQUES; URACIL-DNA GLYCOSIDASE; VIRION; VIRUS REPLICATION;

EID: 0033925801     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.15.7039-7047.2000     Document Type: Article

References (53)

1. Bachand, F., X.-J. Yao, M. Hrimech, N. Rougeaum, and E. A. Cohen. 1999. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J. Biol. Chem. 274:9083-9091.
2. Baltimore, D. 1970. RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature (London) 226:1209-1211.
3. Bouhamdan, M., S. Benichou, F. Rey, J.-M. Navarro, I. Agostini, B. Spire, J. Camonis, G. Slupphaug, R. Vigne, R. Benarous, and J. Sire. 1996. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:697-704.
4. Coffin, J. 1992. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:143-164.
5. Coffin, J. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
6. Coffin, J. M. 1996. Retroviridae: the viruses and their replication, p. 1767-1847. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
7. Cohen, E. A., G. Dehni, J. G. Sodroski, and W. A. Haseltine. 1990. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:3097-3099.
8. Di Marzio, P., S. Choe, M. Ebright, R. Knoblauch, and N. R. Landau. 1995. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:7909-7916.
9. Elder, J. H., D. L. Lerner, C. S. Hasselkus-Light, D. J. Fontenot, E. Hunter, P. A. Luciw, R. C. Montelaro, and T. R. Phillips. 1992. Distinct subsets of retroviruses encode dUTPase. J. Virol. 66:1791-1794.
10. Gragerov, A., T. Kino, G. Ilyina-Gragerova, G. P. Chrousos, and G. N. Pavlakis. 1998. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virology 245:323-330.
11. cdc2 activity. J. Virol. 69:6705-6711.
12. Heinzinger, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
13. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
14. Holland, J. J., J. C. De La Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
15. Jenkins, Y., M. McEntee, K. Weis, and W. C. Greene. 1998. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143:875-885.
16. Jowett, J. B., Y.-M. Xie, and I. S. Y. Chen. 1999. The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector. J. Virol. 73:7132-7137.
17. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
18. Katz, R. A., and A. M. Skalka. 1990. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:409-445.
19. Krokan, H. E., R. Standal, and G. Slupphaug. 1997. DNA glycosylases in the base excision repair of DNA. Biochem. J. 325:1-16.
20. Lerner, D. L., P. C. Wagaman, T. R. Phillips, O. Prospero-Garcia, S. J. Henriksen, H. S. Fox, F. E. Bloom, and J. H. Elder. 1995. Increased mutation frequency of feline immunodeficency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. USA 92:7480-7484.
21. Lichtenstein, D. L., K. E. Rushlow, R. F. Cook, M. L. Raabe, C. J. Swardson, G. J. Kociba, C. J. Issel, and R. C. Montelaro. 1995. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:2881-2888.
22. Lu, Y.-L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:6542-6550.
23. Mahalingam, S., S. A. Khan, R. Murali, M. A. Jabbar, C. E. Monken, R. G. Collman, and A. Srinivasan. 1995. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA 92:3794-3798.
24. Mansky, L. M. 1996. Forward mutation rate of human immunodeficiency virus type 1 in a T-lymphoid cell line. AIDS Res. Hum. Retroviruses 12:307-314.
25. Mansky, L. M. 1996. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virology 222:391-400.
26. Mansky, L. M. 1998. Retrovirus mutation rates and their role in genetic variation. J. Gen. Virol. 79:1337-1345.
27. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
28. Nilsen, H., M. Otterlei, T. Haug, K. Solum, T. A. Nagelhus, F. Skorpen, and H. E. Krokan. 1997. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 25:750-755.
29. Pardo, E. G., and C. Gutierrez. 1990. Cell cycle- and differentiation stage-dependent variation of dUTPase activity in higher plant cells. Exp. Cell Res. 186:90-98.
30. Paxton, W., R. I. Connor, and N. R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type I virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67:7229-7237.
31. Popov, S., M. Rexach, G. Zybarth, N. Reiling, M. A. Lee, L. Ratner, C. M. Lane, M. S. Moore, G. Blobel, and M. Bukrinsky, 1998. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17:909-917.
32. Refaeli, Y., D. N. Levy, and D. B. Weiner. 1995. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92:3621-3625.
33. Rogel, M. E., L. J. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
34. Selig, L., S. Benichou, M. E. Rogel, L. I. Wu, M. A. Vodicka, J. Sire, R. Benarous, and M. Emerman. 1997. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71:4842-4846.
35. Selig, L., J.-C. Pages, V. Tanchou, S. Prévéral, C. Berlioz-Torrent, L. X. Liu, L. Erdtmann, J.-L. Darlix, R. Benarous, and S. Benichou. 1999. Interaction with the p6 domain of the Gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J. Virol. 73:592-600.
36. Sleigh, R., M. Sharkey, M. A. Newman, B. Hahn, and M. Stevenson. 1998. Differential association of uracil DNA glycosylase with SIVsm Vpr and Vpx proteins. Virology 245:338-343.
37. Spector, R., and B. Boose. 1983. Development and regional distribution of deoxyuridine 5′-triphosphate in rabbit brain. J. Neurochem. 41:1192-1195.
38. Steagall, W. K., M. D. Robek, S. T. Perry, F. J. Fuller, and S. L. Payne. 1995. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 210:302-313.
39. Steimer, K. S., J. P. Puma, M. D. Power, M. A. Powers, C. George-Nascimento, J. C. Stephans, J. A. Levy, R. Sanchez-Pescador, P. A. Luciw, P. J. Barr, et al. 1986. Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 150:283-290.
40. Temin, H. M. 1961. Mixed infection with two types of Rous sarcoma virus. Virology 13:158-163.
41. Temin, H. M. 1993. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA 90:6900-6903.
42. Temin, H. M., and S. Mitzutani. 1970. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (London) 226:1211-1213.
43. Threadgill, D. S., W. K. Steagall, M. T. Flaherty, F. J. Fuller, S. T. Perry, K. E. Rushlow, S. F. J. LeGrice, and S. L. Payne. 1993. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 67:2592-2600.
44. Turelli, P., F. Guiguen, J.-F. Mornex, R. Vigne, and G. Querat. 1997. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J. Virol. 71:4522-4530.
45. Turelli, P., G. Petursson, F. Guiguen, J.-F. Mornex, R. Vigne, and G. Querat. 1996. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70:1213-1217.
46. Vodicka, M. A., D. M. Koepp, P. A. Silver, and M. Emerman. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-185.
47. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
48. Willetts, K. E., F. Rey, I. Agostini, J.-M. Navarro, Y. Baudat, R. Vigne, and J. Sire. 1999. DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J. Virol. 73:1682-1688.
49. Withers-Ward, E. S., J. B. Jowett, S. A. Stewart, Y. M. Xie, A. Garfinkel, Y. Shibagaki, S. A. Chow, N. Shah, F. Hanaoka, D. G. Sawitz, R. W. Armstrong, L. M. Souza, and I. S. Chen. 1997. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71:9732-9742.
50. Yao, X.-J., R. A. Subbramanian, N. Rougeau, F. Boisvert, D. Bergeron, and E. A. Cohen. 1995. Mutageneic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69:7032-7044.
51. Zhao, L.-J., S. Mukherjee, and O. Narayan. 1994. Biochemical mechanism of HIV-1 Vpr function. J. Biol. Chem. 269:15577-15582.
52. Zhou, Y., Y. Lu, and L. Ratner. 1998. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest Virology 242:414-424.
53. Zufferey, R., D. Nagj, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.